A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT07374471 · RECRUITING

Trial details

NCT number: NCT07374471
Sponsor: Mage Biologics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2026-04-01
Primary completion: 2028-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.